Related Experiment Videos
Cardiac xenotransplantation in primates.
The Journal of Thoracic and Cardiovascular Surgery
|June 1, 1987
Summary
Cyclosporine-based immunosuppression significantly prolonged cardiac xenograft survival in baboons when transplanted heterotopically. Further research into the orthotopic model is warranted for potential cardiac xenotransplantation advancements.
Area of Science:
- Transplantation Immunology
- Xenotransplantation Research
- Cardiovascular Surgery
Background:
- The critical shortage of donor organs for cardiac transplantation necessitates alternative solutions like xenotransplantation.
- Previous xenotransplantation attempts had limited success, with minimal investigation into cyclosporine's efficacy in nonhuman models.
- Primate cardiac xenograft models offer a valuable platform for studying immunosuppressive strategies.
Purpose of the Study:
- To investigate the effectiveness of cyclosporine-based immunosuppression in primate cardiac xenograft models.
- To compare graft survival rates between heterotopic and orthotopic xenotransplantation with varying immunosuppressive regimens.
- To assess the potential of xenotransplantation as a viable alternative for cardiac replacement.
Main Methods:
- Cardiac xenotransplantation was performed using cynomolgus monkey donors and baboon recipients in heterotopic and orthotopic positions.
- Recipients received no immunosuppression (controls), cyclosporine and steroids, or a combination of cyclosporine, steroids, azathioprine, and antithymocyte globulin.
- Graft survival times were meticulously recorded and statistically analyzed to compare different treatment groups.
Main Results:
- Heterotopic cardiac xenografts showed statistically significant prolongation of survival with cyclosporine-based immunosuppression compared to controls.
- Mean graft survival in heterotopic xenografts treated with cyclosporine and steroids was 61 days (p = 0.01), and with additional agents was 84 days (p < 0.01).
- No significant increase in graft survival was observed in orthotopic xenograft models, irrespective of the immunosuppressive regimen used.
Conclusions:
- Cyclosporine-based immunosuppression can significantly enhance cardiac xenograft survival in heterotopic primate models.
- The orthotopic xenotransplantation model requires further investigation despite the lack of significant survival benefit in this study.
- While not yet a definitive solution for cardiac replacement, these findings support continued research into primate cardiac xenotransplantation.